Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

40results about How to "The content of active ingredients is stable" patented technology

Method for preparing nalmefene hydrochloride injection and prepared nalmefene hydrochloride injection

The invention discloses a method for preparing nalmefene hydrochloride injection. The method comprises the steps of adding a certain amount of citric acid or citrate auxiliary material to the preparation when the nalmefene hydrochloride injection is prepared according to a common method, wherein the adding amount is 5-15g of citric acid or citrate added to each liter of injection; firstly, taking the prescribed auxiliary material in preparation, adding injection water to dissolve, adding active carbon to agitate and adsorb, filtering and removing impurities; adding the prescribed nalmefene hydrochloride under the protection of nitrogen, fully dissolving and sizing to an appointed constant volume by water, adjusting the pH value to 3.5-4.5; and finally conducting split charging, charging nitrogen, sealing and sterilizing after filtering by a filter. By adopting the method disclosed by the invention, the validity period of the nalmefene hydrochloride injection can be obviously prolonged; a specific citric acid pH value stabilizer is adopted; and the nalmefene hydrochloride injection has good stability, and stable sample appearance, pH value, effective ingredient content and related substances, and the like. Therefore, the safety of medication is ensured.
Owner:ANHUI HEALSTAR PHARM CO LTD

Preparation technology of radix salviae miltiorrhizae tablets

The invention provides a preparation technology of radix salviae miltiorrhizae tablets. The preparation technology comprises the steps of cutting radix salviae miltiorrhizae medicinal materials in different batches into segments, detecting the extracts of radix salviae miltiorrhizae decoction pieces, and detecting the content of effective components, wherein (Chinese Pharmacopoeia) the radix salviae miltiorrhizae medicinal materials contain 3.0% or above of Salvianolic acid B, the total extracts are not less than 50.0%, according to different extracts and the content of the effective components, preparation is performed, so that the total extracts are 65%-75%, and the content of the Salvianolic acid B is 7%-9%; placing the decoction pieces prepared in the proportion in an extracting tank,adding 90% alcohol, performing extraction for 1.0 hour, and concentrating outlet liquid; adding water, and performing extraction for 1.5 hours; concentrating outlet liquid; merging the concentrated liquid, and then performing concentration once again; and performing spray drying, collecting powder, then performing granulation, and performing tabletting so as to obtain the radix salviae miltiorrhizae tablets. The preparation technology is suitable for industrial production.
Owner:上海蔡同德堂中药制药厂有限公司

Chinese medicine composition for preventing and treating hyperuricemia and hyperlipemia and preparation method thereof

ActiveCN105749072AMeet the characteristics of long-term medicationWith dehumidification and seepageMetabolism disorderSkeletal disorderCannabisSide effect
The invention discloses a Chinese medicine composition for preventing and treating hyperuricemia and hyperlipemia and a preparation method thereof, and relates to medicine or health-care food for preventing and treating hyperuricemia and hyperlipemia.The Chinese medicine composition for preventing and treating hyperuricemia and hyperlipemia contains extract of a Chinese medicine formula, and according to the formula, the Chinese medicine composition is prepared from, by weight, 3-20 parts of coix seeds, 5-40 parts of glabrous greenbrier rhizome, 3-20 parts of plantain herbs, 1-9 parts of Chinese atractylode rhizome, 1-12 parts of the root of bidentate achyranthes, 1-9 parts of papaw and 1-9 parts of fructus cannabis.The Chinese medicine composition has the functions of clearing away dampness, eliminating water seepage and inducing diuresis for treating stranguria, can obviously regulate and treat the hyperuricemia and hyperlipemia and is free of toxic and side effects after being taken for a long time; the preparation technology is stable, and production feasibility is good.The medicine or health-care food for preventing and treating the hyperuricemia and hyperlipemia contains an effective dose of the Chinese medicine composition for preventing and treating the hyperuricemia and hyperlipemia.
Owner:SHENZHEN ELDERLY MEDICAL RES INST +2

Herbicide composition dispersible oil suspending agent and preparation method thereof

ActiveCN113491269AGood dispersion effectOvercoming easily decomposedBiocideAnimal repellantsWeedZinnia elegans
The invention belongs to the field of agricultural herbicides, and relates to a herbicide composition dispersible oil suspending agent and a preparation method thereof. The invention also relates to the use of the dispersible oil suspending agent for preventing unwanted plant growth. The dispersible oil suspending agent comprises the following components in percentage by weight: 0.1-20% of an active component A, 1-60% of an active component B, 1-30% of a surfactant, 0.1-5% of a pH regulator, 0.5-5% of a structure stabilizer, 0-20% of a solvent and the balance of an oil base, wherein the active component A is a compound as shown in a formula I, and the active component B is selected from glyphosate and agrochemically applicable salts or esters thereof. The dispersible oil suspending agent provided by the invention is stable and free of physical unstable phenomena such as creaming and bottom formation during heat storage, and the effective components are not easy to decompose. The herbicide composition disclosed by the invention can be used for preventing and treating various weeds, especially broadleaf weeds such as piemarker and zinnia elegans, and has an excellent prevention effect.
Owner:SHENYANG SINOCHEM AGROCHEMICALS R&D CO LTD +1

Preparation method of herba centellae substitutional tea

The invention discloses a preparation method of herba centellae substitutional tea. The preparation method comprises the steps of (1) collecting: collecting centella leaves in two seasons of summer and autumn; (2) cleaning and selecting: removing foreign matters, branches or yellow leaves; (3) spreading for cooling: ventilating and spreading for cooling the centella at 26 to 30 DEG C; (4) de-enzyme: performing de-enzyme treatment on the centella leaves; (5) molding: putting raw materials after de-enzyme on rolling equipment, spreading for cooling firstly, then rolling to obtain strip decoction pieces; (6) drying: drying the rolled leaves under the condition that the temperature is 50 to 110 DEG C and the thickness is 1.0 to 3.0 cm, and the drying time is 1 to 2h; (7) controlling the humidity of the dried herba centellae substitutional tea to below 60 percent, and cooling the dried herba centellae substitutional tea to room temperature, and then performing subpackage to obtain a finished product. According to the preparation method of the herba centellae substitutional tea, all aspects such as the purity of materials, sensation of sense organs of the color, shape, smell and the like of the tea, the mobility of yield production, moisture and ash content, the content of active ingredients, long-term stability, brewing property of the decoction pieces, and the like are obviously superior to that of the existing technical scheme.
Owner:GUANGZHOU HANFANG PHARMA

Preparation method and detection method of salvia miltiorrhizagranules

The invention provides a preparation method and a detection method of salvia miltiorrhizagranules. The preparation methodcomprises the following steps: salvia miltiorrhiza is taken as the raw material, soaked and extracted by ethanol to prepare clear paste, auxiliary materials are added, and the mixture is granulated to prepare a product. The method is simple, effective components are completely retained, the content is higher, the cost is low, the quality of the prepared salvia miltiorrhizagranules can be guaranteed, and the method is suitable for industrial production. For component detection of the detection method, salvia miltiorrhizareference crude herb, a tanshinone II A reference substance, acryptotanshinone reference substance, atanshinolreference substance, asalvianolic acid B reference substance and a protocatechualdehyde reference substance are taken as reference for effective component detection, salvianolic acid B is taken as the reference substance for content determination, the adopted component detection method has high specificity, the accuracy of content determination is high, the effective components are completely retained, the content is stable, and the quality of the prepared salvia miltiorrhizagranules is guaranteed, so that the synergistic effect of components of salvia miltiorrhiza is guaranteed, the efficacy of the salvia miltiorrhizagranulesis guaranteed, and the health of people is protected.
Owner:九寨沟天然药业股份有限公司

Artemisia rupestris L pill and production method and application thereof

ActiveCN101837037BObvious anti-inflammatory and analgesic effectSolve problems such as hazardsAntipyreticAnalgesicsPolyethylene glycolRheumatism
The invention relates to an artemisia rupestris L pill and a production method and application thereof, the method comprises the following steps: step I: CommonSt.John'swortHerb and artemisia rupestris L with equal quantity are mixed and are crushed into coarse powder, ethanol is added for backflow extraction, the extracting solution is filtered, cooled and centrifuged, and then supernate is concentrated; step II: the concentrated solution is purified by macroporous absorption resin, and effluent liquid is collected in different segments, the effluent liquid is concentrated and is dried to obtain extract powder for spare; step III: the dry extract powder is mixed with polyethylene glycol according to proportion, the mixture is melted by heating, and then pills are produced by dropping. The process in the invention is stable and reliable, the contents of effective ingredients in the pills are stable; the invention solves the problem that residual organic solvent caused by the extraction of organic solvents such as petroleum ether, ethyl acetate and the like is harm to human bodies. Compared with the prior art, the method in the invention is suitable industrial production; the artemisia rupestris L pill obtained in the invention has obvious anti-inflammatory analgesic activities which are proved by experiments in pharmacodynamics and is used for treatment of rheumatism and rheumatoid arthritis.
Owner:XINJIANG QUANAN PHARMA

Preparation and detection methods of salvia miltiorrhiza shuxin capsule

The invention provides preparation and detection methods of a salvia miltiorrhiza shuxin capsule. The preparation method comprises the steps of soaking salvia miltiorrhiza serving as a raw material, and extracting by using ethanol to prepare clear paste; and adding auxiliary materials, and encapsulating to obtain the salvia miltiorrhiza shuxin capsule. The preparation method is simple, capable of completely retaining effective components and ensuring relatively-high effective component content and the quality of the salvia miltiorrhiza shuxin capsule, low in cost and also suitable for industrial production. The detection method comprises the steps of detecting effective components by taking a salvia miltiorrhiza reference medicine, a tanshinone IIA reference substance, a cryptotanshinone reference substance, a tanshinol reference substance, a salvianolic acid B reference substance and a protocatechualdehyde reference substance as references; and detecting content by taking salvianolic acid B as a reference substance. The adopted detection method for the components is strong in specificity, high in content detection accuracy, complete in effective component retention and capable of ensuring stable effective component content and the quality of the salvia miltiorrhiza shuxin capsule, so that all the components in salvia miltiorrhiza can take a synergistic effect, the curative effect is ensured, and the health of people is protected.
Owner:SICHUAN FENGCHUN PHARMA

Preparation method of siraitia grosvenorii compound capsules

The invention discloses a preparation method of siraitia grosvenorii compound capsules. The preparation method comprises the following steps: crushing raw and auxiliary materials; screening the crushed raw and auxiliary materials; mixing the screened raw and auxiliary materials; pelleting the mixed raw and auxiliary materials; coating the pelleted raw and auxiliary materials; drying the coated raw and auxiliary materials; stuffing the capsules. Each of the siraitia grosvenorii compound capsule comprises the following raw and auxiliary materials in parts by weight: 23-27% of siraitia grosvenorii compound extracts, 5-10% of persimmon powder, 30-35% of corn starch, 25-30% of maltodextrin and 5-10% of microcrystalline cellulose. The siraitia grosvenorii compound extracts use a siraitia grosvenorii extracting solution as a solvent and dried tea leaves of dried aloe leaves, dried shrub althea flowers and dried sweet basil herb as the raw materials so as to perform the extraction, the mass ratio of the dried aloe leaves to the dried shrub althea flowers and the dried sweet basil herb is 2:(0.5-2.0):(1-1.5):(0.1-1), and the material-solvent ratio is 1:(5-10); The siraitia grosvenorii compound capsules prepared by the preparation method disclosed by the invention have the oxidation resistant effect, the bacteriostasis effect and the immunity enhancing effect.
Owner:GUILIN UNIV OF ELECTRONIC TECH

Preparation method of nalmefene hydrochloride injection and nalmefene hydrochloride injection prepared with method

The invention discloses a preparation method of a nalmefene hydrochloride injection. When the nalmefene hydrochloride injection is prepared with a conventional method, a certain quantity of citric acid or citrate auxiliary material is added to the preparation, and 5-15 g of the citric acid or citrate auxiliary material is added in each liter of the injection. During preparation, the prescription quantity of the auxiliary material is dissolved in water for injection firstly, then activated carbon is added with stirring for adsorption, and filtration is performed for impurity removal; the prescription amount of nalmefene hydrochloride is added under the nitrogen protection, after full dissolution, the solution is metered to the designated volume with water, the pH value is adjusted to 3.5-4.5, and finally, the solution is filtered by a filter, sub-packaged, filled with nitrogen, sealed and sterilized. With the adoption of the method, the expiry date of the nalmefene hydrochloride injection can be obviously prolonged, the stability is good due to adoption of a specific citric acid pH value stabilizer, the sample appearance properties, pH value, effective ingredient content, related substances and the like are relatively stable, and the medication safety is guaranteed.
Owner:威海恒基伟业信息科技发展有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products